We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Sues Watson Over Application to Market Generic Evista Tablets
Lilly Sues Watson Over Application to Market Generic Evista Tablets
May 11, 2010
Eli Lilly has filed a patent-infringement suit against Watson Pharmaceuticals after the company submitted an application to market a generic version of Lilly’s postmenopausal osteoporosis drug Evista.